About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Long-term Treatment with Blood Thinner Delays Onset of Alzheimer''s
Advertisement

Long-term Treatment With Blood Thinner Delays Onset of Alzheimer’s

Font : A-A+

Highlights:
  • Alzheimer’s disease is a neurodegenerative, memory disorder with strong factors like vascular and hemostatic changes
  • A research study published in the Journal of American College of Cardiology indicates how a common blood thinner, Dabigatran can stall the onset and progression of Alzheimer’s disease in mouse models
  • This study proved that long term use of dabigatran can prevent cognitive decline, improve cerebral blood flow, reduce amyloid deposits and reduce neuroinflammation
  • The results open up a new field to study how this can be translated to therapeutic benefits for Alzheimer’s patients

A research study published in the Journal of American College of Cardiology indicates how a common blood thinner, Dabigatran can stall the onset and progression of Alzheimer's disease in mouse models. Alzheimer's disease (AD) is a progressive neurodegenerative disorder that involves the deposition of amyloid plaques, tau tangles, neuroinflammation and brain atrophy. It has a strong cardiovascular risk and often presents with blood-brain barrier disruption, reduced cerebral blood flow and fibrin clots.

Advertisement

Long-term Treatment With Blood Thinner Delays Onset of Alzheimer’s

The team used TgCRND8 AD mice and nontransgenic littermates (as controls). The mice were provided by The Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Canada. Only female mice were used as male littermates were aggressive. The team obtained 70 female mice through in vitro fertilization - 7 TgCRND8 and 33 wild-type (WT) mice.

Two-month old TgCRND8 AD mice and nontransgenic littermates were randomized into groups which received food supplemented with 5 mg/g of dabigatran etexilate (BIBR 1048) or placebo. Both drug and placebo were provided by Boehringer Ingelheim, Germany. The mice were treated till they were 30 weeks old.
Advertisement

The team found that AD mice treated with dabigatran were able to successfully negotiate the test of Barnes maze to assess spatial memory at 25 weeks whereas placebo treated mice were not up to the task. The mice were then sacrificed at 30 to 60 weeks and blood and brain tissue were collected for histology and immunohistochemistry.

The mice treated with dabigatran showed positive improvement with prevention of memory decline, improved blood flow in the cerebral area and reduction of toxic fibrin deposits in the brain. The dabigatran treated mice also showed reduction in the deposit of amyloid plaques, oligomers, phagocytic microglia and infiltrated T cells.

This study proved that long term use of dabigatran can prevent cognitive decline, improve cerebral blood flow, reduce amyloid deposits and reduce neuroinflammation. Dabigatran actually inhibited thrombin and excessive deposition of fibrin in the brain thereby preserving blood flow, facilitating oxygen and rich nutrient delivery to the brain. The results open up a new field to study how this can be translated to therapeutic benefits for Alzheimer's patients.

Reference :
  1. Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model - (http://www.onlinejacc.org/content/74/15/1910)


Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
Smallpox
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Thalassemia Congenital Heart Disease Anticoagulants Hemophilia Blood in Stools - Symptom Evaluation Bombay Blood Group Common Side Effects of Anticoagulants / Blood Thinners 

Recommended Reading
Oral Anticoagulants or Blood Thinners
Warfarin is the most commonly used oral anticoagulant. Dabigatran etexilate is a newer drug ......
Sleep Naturally Prevents The Accumulation of Alzheimer's Disease-Causing Proteins
Sleep has been found to be metabolic cleaner for amyloid beta proteins that are usually responsible ...
Simple Blood Test can Detect Alzheimer's Risk: Study
Simple blood test measuring the neurofilament light protein (NFL) concentration in the blood can ......
Protective Factor Against Alzheimer’s Disease Discovered
Higher levels of TREM2 were associated also with a reduced rate of the development of full blown ......
Anticoagulants
Anticoagulants prevent the clotting of blood in our body. They are administered orally or via ......
Blood in Stools - Symptom Evaluation
Blood in stools results from bleeding that arises from any part of the digestive tract. Causes of bl...
Bombay Blood Group
Bombay blood group is a rare blood type in which the people have an H antigen deficiency. They can r...
Common Side Effects of Anticoagulants / Blood Thinners
The main side effect of anticoagulants or blood thinners is bleeding. Others include reduced platele...
Congenital Heart Disease
Heart diseases that are present at birth are called “ Congenital heart diseases”....
Hemophilia
Hemophilia is a rare single gene, X- linked disorder, which tends to run in families....
Thalassemia
Thalassemia is an inherited blood disorder passed on through parental genes causing the body to prod...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use